secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0000950170-25-016321
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla receives Nasdaq notice of non-compliance with minimum bid price rule; 180 days to cure
--------------------------------------------------------------------------------

- Received Nasdaq notice on Feb 6, 2025 for failing minimum bid price of $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Aug 5, 2025) to regain compliance.
- Compliance can be achieved by maintaining $1.00 closing bid for 10 consecutive business days.
- Additional 180-day compliance period possible if transferred to Nasdaq Capital Market.
- If not cured, common stock subject to delisting; company considering options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025016321/0000950170-25-016321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025016321/bcab-20250206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-016321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer